Get the Stockscreener App
11.10
0.72%
-0.08
After Hours:
11.10
Clearpoint Neuro Inc stock is traded at $11.10, with a volume of 299.68K.
It is down -0.72% in the last 24 hours and up +18.46% over the past month.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
See More
Previous Close:
$11.18
Open:
$11.31
24h Volume:
299.68K
Relative Volume:
0.42
Market Cap:
$332.84M
Revenue:
$36.97M
Net Income/Loss:
$-25.54M
P/E Ratio:
-12.30
EPS:
-0.9022
Net Cash Flow:
$-24.45M
1W Performance:
+0.18%
1M Performance:
+18.46%
6M Performance:
-34.63%
1Y Performance:
-20.03%
1-Day Range:
$10.71
$11.35
1-Week Range:
$10.15
$11.73
52-Week Range:
$8.27
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
11.10 | 335.24M | 36.97M | -25.54M | -24.45M | -0.9022 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Oct-24-23 | Initiated | Stifel | Buy |
| Feb-16-23 | Resumed | B. Riley Securities | Buy |
| Apr-05-22 | Resumed | B. Riley Securities | Buy |
| Mar-18-21 | Initiated | Lake Street | Buy |
| Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
Discipline and Rules-Based Execution in CLPT Response - Stock Traders Daily
ClearPoint Neuro to report first quarter 2026 results on May 13 - Traders Union
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026 - ACCESS Newswire
ClearPoint Neuro schedules May 13 earnings call after market close - Stock Titan
ClearPoint Neuro, Inc. Q4 2025 earnings preview - MSN
ClearPoint Neuro: Temporary Headwinds Don't Change The Long-Term Outlook - Seeking Alpha
ClearPoint Neuro (CLPT) moves 8.1% higher: Will this strength last? - MSN
Here’s why biotech UniQure’s stock just tripled, and brought ClearPoint shares up with it - MSN
ClearPoint Neuro plunges as FY26 guidance falls below analysts' estimates - MSN
Clearpoint Neuro, Valneva, Rocket Lab and other big stocks moving lower in Wednesday's pre-market session - MSN
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint - Chronicle-Tribune
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint - News-Press NOW
Behavioral Patterns of CLPT and Institutional Flows - Stock Traders Daily
ClearPoint Neuro | DEFA14A: Others - Moomoo
[ARS] ClearPoint Neuro, Inc. SEC Filing - Stock Titan
ClearPoint Neuro completes first procedure with new drill system By Investing.com - Investing.com India
Lake Street Initiates ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $30 - Moomoo
ClearPoint (CLPT): Buy, Sell, or Hold? | Q4 2025: Earnings Fall ShortCommunity Sell Signals - Cổng thông tin điện tử tỉnh Lào Cai
ClearPoint Neuro (CLPT) Achieves Milestone with New Surgical Dri - GuruFocus
ClearPoint Neuro completes first procedure with new drill system - Investing.com
ClearPoint Neuro wins FDA clearance for Velocity Alpha MR High Speed Surgical Drill System - Traders Union
ClearPoint's brain surgery drill gets FDA clearance, first clinical use - Stock Titan
Analysts Offer Insights on Healthcare Companies: Monopar Therapeutics Inc (MNPR), ClearPoint Neuro (CLPT) and CG Oncology, Inc. (CGON) - The Globe and Mail
ClearPoint Neuro Completes First Clinical Procedure with New Surgical Drill - Intellectia AI
CLPT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Stocks Shoot Up 25% But Its P/S Still Looks Reasonable - 富途牛牛
ClearPoint Neuro receives Canadian clearance for navigation system By Investing.com - Investing.com India
ClearPoint Neuro gets Canadian approval for navigation system - Investing.com
ClearPoint Neuro (NASDAQ:CLPT) Trading Down 5.3%Should You Sell? - MarketBeat
ClearPoint Neuro gets Canadian approval for navigation system By Investing.com - Investing.com India
ClearPoint Neuro receives Canadian clearance for navigation system - Investing.com
ClearPoint Neuro (CLPT) Receives Medical Device License from Hea - GuruFocus
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug De - PharmiWeb.com
Bigger Capital Group (CLPT) files ownership update showing 7.54% attributed to Michael Bigger - Stock Titan
Canadian regulators clear ClearPoint Neuro navigation system, expanding device reach - Traders Union
Canada clears ClearPoint brain navigation system for clinical trial sites - Stock Titan
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint | FinancialContent - FinancialContent
(CLPT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):